Page results
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.
-
UCLH is managing one of the three cancer hubs across London, so that during the COVID-19 coronavirus pandemic cancer surgery is available for patients with the most immediate needs.
-
One of our patients who is recovering from COVID-19 has been appearing across national media as she recounts her story and thanks the staff who saved her life.
-
The special haematology service provides a comprehensive investigation of haemolytic amaemia, haemoglobinopathies and red cell enzymopathy.
-
Information on how we ask for your consent to treatment, and Martha's Rule.
-
Patients recovering from coronavirus have spoken movingly about the physical and emotional legacy of the disease.
-
Acute loss of sense of smell should be considered globally as a criterion for self-isolation, testing, and contact tracing for Covid-19 infection according to researchers at UCLH and UCL.
-
Breathing aids developed by engineers at UCL, UCLH and Mercedes-AMG High Performance Powertrains have been delivered to 40 NHS hospitals across the country.
File results
-
FOI/2021/0734 - Sexual harassment against catering staff
-
FOI/2021/0749 - Private contractors
-
FOI/2021/0751 - TB Find and Treat programme
-
FOI/2022/0002 - Patient Portal / Patient Access Portal system
-
FOI/2022/0007 - Priory Group services at the Trust
-
FOI/2022/0008 - Functional electrical stimulation devices
-
FOI/2022/0012 - Paediatric antibiotic guideline
-
FOI/2022/0014 - Water treatment equipment in sterile services department
-
FOI/2022/0042 - Thermometers used at Trust
-
FOI/2022/0023 - Assault attendances to ED